Reverse Pharmacology and the R&D of Modern Analgesic Based on Traditional Medicines

作者: 陈素 , 黄先菊 , 刘向明 :;

关键词: 龙血竭野木瓜河豚毒素不敏感型纳通道瞬时感受器电位香草酸受体1反向药理学<br>Dragon’s Blood Resin Stauntonia Chinensis DC. Tetrodotoxin-Resistant Sodium Channel Transient Potential Vanilloid Receptor1 Reverse Pharmacology

摘要: 疼痛是许多急慢性疾患中皆可出现的症状,它是危及人类健康及防碍正常生活的主要问题之一。为了抗御疼痛,人类一直在孜孜不倦地寻求镇痛药物。目前临床上使用最多的镇痛药是以吗啡为代表的阿片生物碱类及其合成代用品(或称阿片类药物——opioids)和非甾体抗炎药(Nonsteroidal Antiinflammatory Drugs,NSAIDs),它们都有较为严重的毒、副作用。一些致痛因子和炎性介质,如5-HT,ATP,BK,His,PGE2,SP等,其相应的受体阻断剂的应用对于镇痛虽有一定效应,但由于此等受体分布广泛,故选择性作用部位不强而且副作用也较多。因此关注的焦点主要集中在探索表达于中、小直径的初级感觉神经元的河豚毒素不敏感型(tetrodotoxin-resistant,TTX-R)钠通道和瞬时感受器电位香草酸受体1(transient potential vanilloid receptor1,TRPV1)。遗憾的是多年来在这方面并无突破性进展。以植物为本的各民族传统药物是当今国际药品市场的潜在丰富来源。遵循“反向药理学”的研究模式,形成先导物发现可践行的方法学,结合先进的科学技术和方法,从长期临床应用证实具有较显著镇痛功效和较少毒、副作用的传统药物中提取、分离多种单体化学成分,对其进行系统的药理研究,开发出化学结构和镇痛机理明确、安全性高的新型镇痛药物,将是镇痛药研发中具有较高效率的新途径。在我们的研究中,发现了两种对TTX-R钠通道和TRPV1均具有调制作用的民族药物——龙血竭和野木瓜。这两种药物在临床上都有较好的镇痛疗效,并且无成瘾性方面的记录。我们还确定了龙血竭调制TTX-R钠通道和TRPV1的药效物质基础是其化学成分剑叶龙血素A、剑叶龙血素B和龙血素B的组合。

Abstract: Pain is a major symptom in many medical conditions, and can significantly interfere with a person’s quality of life and general function. To relieve pain, people are unwearied to look for the analgesic drugs. Nowadays, the most popular analgesics in clinic practice are opioids and non-steroidal anti-inflammatory drugs (NSAIDs), both of which have some adverse reactions. Although the antagonists of some painful factor such as 5-HT, ATP, BK, His, PGE2 and SP receptors can relieve pain to some extent, they have some unpleasant side-effects and low selectivity for analgesic sites due to the wide distribution of them. Therefore, the focus of the research was concentrated on tetrodotoxin-resis- tant (TTX-R) sodium channel and transient potential vanilloid receptor 1(TRPV1) distributed in small-to-medium-sized primary sensory neurons. However, little breakthrough has been made for the past many years. The plentiful plant-derived national traditional medicine are potential resource of international pharmaceutical market nowadays. Based on the research framework of reverse pharmacology, combined with advanced science technique and methods, shaping into feasible methodology of discovering lead compounds, a new approach of developing analgesics is to ex- tract and separate various monomers from traditional medicine which have been confirmed significant efficacy and low side effect in clinic practice for a long period. The monomers will then be investigated systematically and developed into new analgesics with identified chemicial construction, clear-cut mechanism and high security. Our study discovered that two ethnodrugs, Dragon’s Blood Resin and Stauntonia chinensis DC., could interfere with pain messages and modulate TTX-R sodium and TPVR1 channels. They could produce excellent analgesic therapy in clinic without drug addiction. Moreover, the material basis for the modulation on TTX-R sodium channel and TPVR1 of Dragon’s Blood Resin was successfully validated to be the effective combination of cochinchinenin A, cochinchinenin B and loureirin B.

文章引用: 陈素 , 黄先菊 , 刘向明 (2012) 反向药理学和基于传统药物的现代镇痛药的研发。 中医学, 1, 1-8. doi: 10.12677/tcm.2012.11001


[1] J. M. Bjordal, A. Klovning, A. E. Ljunggren and L. Slordal. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo- controlled trials. European Journal of Pain, 2007, 11(2): 125- 138.

[2] R. A. Moore, S. Derry, G. T. Makinson and H. J. McQuay. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: Systematic review and meta- analysis of information from company clinical trial reports. Arthritis Research & Therapy, 2005, 7(3): R644-R665.

[3] E. Kalso, J. E. Edwards, R. A. Moore and H. J. McQuay. Opi- oids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain, 2004, 112(3): 372-380.

[4] R. Chou, G. J. Fanciullo, P. G. Fine, J. A. Adler; et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Journal of Pain, 2009, 10(2): 113-130.

[5] R. S. Gregorian Jr, A. Gasik, W. J. Kwong, S. Voeller and S. Ka- vanagh. Importance of side effects in opioid treatment: A trade- off analysis with patients and physicians. Journal of Pain, 2010, 11(11): 1095-108.

[6] C. Scarpignato, R. H. Hunt. Nonsteroidal antiinflammatory drug- related injury to the gastrointestinal tract: Clinical picture, path- ogenesis, and prevention. Gastroenterological Clinical of North America, 2010, 39(3): 433-464.

[7] D. Julius, A. L. Basbaum. Molecular mechanisms of nociception. Nature, 2001, 413: 203-210.

[8] G. R. Lewin, Y. Lu and T. J. Park. A plethora of painful molecules. Current Opinion in Neurobiology, 2004, 14(2): 443-449.

[9] M. D. Baker, J. N. Wood. Involvement of Na+ channel in pain pathways. Trends in Pharmacological Science, 2001, 22(!): 27- 31.

[10] M. Tanaka, T. R. Cummins, K. Ishikawa, et al. SNS Na+ channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model. Neuroreport, 1998, 9(6): 967- 972.

[11] A. N. Akopian, V. Souslova, S. England, et al. The tetrodotoxin- resistant sodium channel SNS has a specialized function in pain pathways. Nature Neuroscience, 1999, 2(6): 541-548.

[12] J. Lai, M. S. Gold, C. S. Kim, et al. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. Pain, 2002, 95(1-2): 143-152.

[13] X. Fang, L. Djouhri, J. A. Black, et al. The presence and role of the tetrodotoxin-resistant sodium channel Na(v)1.9 (NaN) in nociceptive primary afferent neurons. Journal of Neuroscience, 2002, 22(17): 7425-7433.

[14] H. Wang, C. J. Woolf. Pain TRPs. Neuron, 2006, 46: 9-12.

[15] I. Nagy, P. Santha, G. Jancso and L. Urban. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. European Journal of Pharmacology, 2004, 50: 351-369.

[16] M. Petersen, R. H. LaMotte. Effect of protons on the inward current evoked by capsaicin in isolated dorsal root ganglion cells, Pain, 1993, 54(1): 37-42.

[17] H. U. Zeihofer, M. Kress and D. Swandulla. Fractional Ca2+ currents through capsaicin- and proton-activated ion channels in rat dorsal root ganglion neurons. Journal of Physiology, 1997 503 (1): 67-78.

[18] G. Jancso, S. Karcsu, E. Kiraly, et al. Neurotoxin induced nerve cell degeneration: Possible involvement of calcium. Brain Research, 1984, 295(2): 211-216.

[19] A. Szallasi, P. M. Blumberg. Vanilloid receptors: New insights enhance potential as a therapeutic target. Pain, 1996, 68(2-3): 195-208.

[20] J. B. Davis, J. Gray, M. J. Gunthorpe, et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature, 2000, 405(6783): 183-187.

[21] B. Patwardhan, A. D. B. Vaidya and M. Chorghade. Ayurveda and natural products drug discovery. Current Science, 2004, 86 (6): 789-799.

[22] Y.-J. Surh. Reverse pharmacology applicable for botanical drug development-inspiration from the legacy of traditional wisdom. Journal of Traditional and Complementary Medicine, 2011, 1(1): 5-7.

[23] G. H. Du. Application of high throughput screening in the field of drug discovery. Basic Medical Sciences and Clinics, 2001, 21(4): 289-293.

[24] 才亚贤. 止痛中药介绍[J]. 陕西中医函授, 1991, (5): 17-18.

[25] 彭援. 植物药镇痛作用的研究进展[J]. 中国野生植物资源, 2005, 24(1): 20-22.

[26] 陈昕. 乌头类中药的研究进展[J]. 时珍国医国药, 2002, 13(12): 7S8-759.

[27] 汪倪萍. 中药活性成分的抗炎免疫和镇痛作用[J]. 中国药理学通报, 2003, 19(4): 366-369.

[28] 邱鲁婴. 三棱总黄酮镇痛作用研究[J]. 时珍国医国药, 2000, 11(4): 291-292.

[29] 杨伟鹏. 野生雪莲和培养雪莲总黄酮主要药效作用比较研究[J]. 中国中医药信息杂志, 2006, 13(1): 32-35.

[30] 吴承艳. 止痛中药的研究与思考[J]. 中华实用中西医杂志, 2005, 18(22): 1633-1635.

[31] X. M. Liu, S. Chen, Y. X. Zhang and F. Zhang. Modulation of dragon’s blood on tetrodotoxin-resistant sodium currents in dorsal root ganglion neurons and identification of its material basis for efficacy. Science in China Series C-Life Sciences, 2006, 49 (3): 274-285.

[32] 刘向明, 陈素. 龙血竭外周镇痛效应的药理研究和反向药理学[J]. 中南民族大学学报(自然科学版), 2008, 27(3): 40-46.

[33] 陈婷, 廖天安. 血竭胶囊对拔牙术后止血、镇痛疗效观察[J]. 海南医学, 2002, 13(10): 48.

[34] 向金莲, 张路晗, 程睿等. 血竭消炎止痛作用研究[J]. 时珍国医国药, 2001, 12(2): 110-111.

[35] 曾雪瑜, 何飞, 李友娣等. 广西血竭的消炎止痛作用及毒性研究[J]. 中国中药杂志, 1999, 24(3): 171-173.

[36] X. M. Liu, S. Chen, S. J. Yin and Z. N. Mei. Effects of dragon’s blood and its component loureirin B on tetrodotoxin-sensitive voltage-gated sodium currents in rat dorsal root ganglion neurons. Science in China Series C-Life Sciences, 2004, 47(4): 340- 348.

[37] M. S. Gold, D. B. Reichling, M. J. Shuster, et al. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proceeding of the National Academy of Science USA, 1996, 93: 1108-1112.

[38] W. J. Lu, X. F. Wang, J. Y. Chen, et al. Studies on chemical con- stituents distilled from Dracaena cochinchinensis with chloroform. Acta Pharmaceutica Sinica, 1998, 33(10): 755-758.

[39] J. Hahn, S. Y. Nah, J. J. Nah, et al. Ginsenosides inhihit capsaicin-activated channel in rat sensory neurons. Neuroscience Letters, 2000, 287(1): 45-48.

[40] J. J. Clare, S. N. Tate, M. Nobbs, et al. Voltage-gated sodium channels as therapeutic targets. Drug Discovery Today, 2000, 5(11): 506-520.

[41] 吴一福. 中药镇痛新药——精制野木瓜注射液[J]. 世界药品信息, 2001, 3(1): 50.

[42] 吴波, 李祚雯. 野木瓜注射液穴位注射治疗坐骨神经痛52例[J]. 湖北中医杂志, 2004, 26(2): 48.

[43] 吴淑兰, 彭慧. 野木瓜注射液用于术后镇痛72例[J]. 医药导报, 2002, 21(9): 570.

[44] 彭小莉, 高喜玲, 陈军等. 鸡矢藤注射液和野木瓜注射液对大鼠足底皮下化学组织损伤诱致自发痛、痛敏和炎症的作用[J]. 药理学报, 2003, 55(5): 516-524.

[45] 叶文博, 刘强, 叶青等. 野木瓜注射液对大鼠隐神经传导的影响[J]. 中草药, 1995, 26(1): 20-21.

[46] 叶文博, 刘强, 李晶. 野木瓜注射液对爪蟾坐骨神经传导的影响[J]. 上海师范大学学报(自然科学版), 1995, 24(3): 64-68.

[47] 叶文博, 薛韶萍, 李劲. 野木瓜注射液对牛蛙坐骨神经传导的影响[J]. 上海师范大学学报(自然科学版), 1997, 26(4): 49- 53.

[48] 叶文博, 戴素梅, 姜芳. 野木瓜注射液对大鼠隐神经内的轴膜和髓鞘的影响[J]. 神经解剖学杂志, 1999, 15(4): 390-392.

[49] J. M. Zhang, D. F. Donnelly, X. J. Song, et al. Axotomy increases the excitability of dorsal root ganglion cells with unmyelinated axons. Journal of Neurophysiology, 1997, 78(5): 2790- 2794.

[50] J. D. England, F. Gamboni, S. R. Levinson, et al. Changed distribution of sodium channels along demyelinated axons. Proceeding of the National Academy of Science, 87: 6777-6780.

[51] 郭世民, 马克坚. 中药镇痛研究新思路[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2008, 17(9): 44-46.